New insights into the biology of tissue factor pathway inhibitor

Por MARONEY, S. A., MAST, A. E.
Publicado no J Thromb Haemost (2015)

Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition

Por Maroney, S. A., Cooley, B. C., Sood, R., Weiler, H., Mast, A. E.
Publicado em 2007

The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.

Por Warshawsky, I, Bu, G, Mast, A, Saffitz, J E, Broze, G J, Schwartz, A L
Publicado em 1995

Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.

Por Mast, A E, Higuchi, D A, Huang, Z F, Warshawsky, I, Schwartz, A L, Broze, G J
Publicado em 1997

Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice

Por Maroney, S. A., Ferrel, J. P., Pan, S., White, T. A., Simari, R. D., Mcvey, J. H., Mast, A. E.
Publicado em 2009

Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease

Por STEPHAN, F., DIENAVA-VERDOOLD, I., BULDER, I., WOUTERS, D., MAST, A. E., TEVELTHUIS, H., AARDEN, L. A., ZEERLEDER, S.
Publicado em 2012

The strategies to reduce iron deficiency in blood donors randomized trial: design, enrolment and early retention

Por Bialkowski, W., Bryant, B. J., Schlumpf, K. S., Wright, D. J., Birch, R., Kiss, J. E., D’Andrea, P., Cable, R. G., Spencer, B. R., Vij, V., Mast, A. E.
Publicado no Vox Sang (2014)